feed,title,long_url,short_url
SeekingAlpha,Rocket Pharma initiates RP-L301 study for red blood cell disorder,https://seekingalpha.com/news/3590500,
SeekingAlpha,Redfin -3% after another valuation-related downgrade,https://seekingalpha.com/news/3590499,
